Susan E. Birket

3.7k total citations
56 papers, 1.7k citations indexed

About

Susan E. Birket is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Susan E. Birket has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Susan E. Birket's work include Cystic Fibrosis Research Advances (34 papers), Neonatal Respiratory Health Research (22 papers) and Tracheal and airway disorders (11 papers). Susan E. Birket is often cited by papers focused on Cystic Fibrosis Research Advances (34 papers), Neonatal Respiratory Health Research (22 papers) and Tracheal and airway disorders (11 papers). Susan E. Birket collaborates with scholars based in United States, Singapore and Italy. Susan E. Birket's co-authors include Steven M. Rowe, Guillermo J. Tearney, Kengyeh K. Chu, Eric J. Sorscher, Linbo Liu, David J. Feola, Theodore J. Cory, Brian S. Murphy, William D. Picking and Marina Mazur and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Susan E. Birket

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Birket United States 24 891 369 220 219 203 56 1.7k
Mark Kühnel Germany 21 244 0.3× 709 1.9× 189 0.9× 124 0.6× 179 0.9× 55 1.7k
Stefan Borgmann Germany 23 266 0.3× 464 1.3× 165 0.8× 180 0.8× 507 2.5× 78 2.3k
Sang Rok Lee South Korea 17 210 0.2× 809 2.2× 85 0.4× 202 0.9× 108 0.5× 141 2.1k
Camille Ehré United States 24 1.4k 1.5× 752 2.0× 122 0.6× 94 0.4× 154 0.8× 44 2.5k
Helen Williams United Kingdom 27 265 0.3× 571 1.5× 56 0.3× 172 0.8× 77 0.4× 84 2.2k
Andrew B. Tullo United Kingdom 32 473 0.5× 520 1.4× 25 0.1× 250 1.1× 147 0.7× 90 3.4k
Eileen Uribe‐Querol Mexico 16 129 0.1× 558 1.5× 101 0.5× 102 0.5× 169 0.8× 31 1.9k
Claudia Chalk United States 23 575 0.6× 299 0.8× 40 0.2× 205 0.9× 163 0.8× 42 1.7k
Mike Hasenberg Germany 22 221 0.2× 709 1.9× 117 0.5× 80 0.4× 642 3.2× 48 2.4k
E Bastounis Greece 21 385 0.4× 321 0.9× 218 1.0× 47 0.2× 47 0.2× 109 1.4k

Countries citing papers authored by Susan E. Birket

Since Specialization
Citations

This map shows the geographic impact of Susan E. Birket's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Birket with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Birket more than expected).

Fields of papers citing papers by Susan E. Birket

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Birket. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Birket. The network helps show where Susan E. Birket may publish in the future.

Co-authorship network of co-authors of Susan E. Birket

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Birket. A scholar is included among the top collaborators of Susan E. Birket based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Birket. Susan E. Birket is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Combs, Stephanie E., et al.. (2025). Pseudomonas aeruginosa increases viscoelasticity and decreases transportability of artificial mucus. iScience. 28(9). 113265–113265.
2.
3.
Liu, Yiwei, Daniel J. Wozniak, Kymberly M. Gowdy, et al.. (2025). Targeting the MEK1/2 pathway to combat Staphylococcus aureus infection and inflammation in cystic fibrosis. mBio. 16(7). e0077525–e0077525. 1 indexed citations
4.
Birket, Susan E., et al.. (2025). Spontaneous lung colonization in the cystic fibrosis rat model is linked to gastrointestinal obstruction. mBio. 16(4). e0388324–e0388324. 1 indexed citations
5.
6.
Shaffer, Katherine A., Kevin J. Ryan, Edward P. Acosta, et al.. (2024). Evaluating the effects of ivacaftor exposure on Staphylococcus aureus small colony variant development and antibiotic tolerance. JAC-Antimicrobial Resistance. 6(6). dlae185–dlae185.
7.
Novak, Lea, et al.. (2023). SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease. Journal of Cystic Fibrosis. 22(6). 1104–1112. 4 indexed citations
8.
Birket, Susan E., et al.. (2023). A novel in vitro model to study prolonged Pseudomonas aeruginosa infection in the cystic fibrosis bronchial epithelium. PLoS ONE. 18(7). e0288002–e0288002. 3 indexed citations
9.
Hisert, Katherine B., Susan E. Birket, John P. Clancy, et al.. (2023). Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy. The Lancet Respiratory Medicine. 11(10). 916–931. 34 indexed citations
10.
Garcia, Bryan, Allister J. Loughran, Susan E. Birket, et al.. (2022). Poly (acetyl, arginyl) glucosamine disrupts Pseudomonas aeruginosa biofilms and enhances bacterial clearance in a rat lung infection model. Microbiology. 168(1). 4 indexed citations
11.
Zheng, Qi, et al.. (2020). Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa. Frontiers in Immunology. 11. 583008–583008. 23 indexed citations
12.
Birket, Susan E., A. Henderson, Liping Tang, et al.. (2020). Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR. American Journal of Respiratory and Critical Care Medicine. 202(9). 1271–1282. 37 indexed citations
13.
Libby, Emily Falk, Lianwu Fu, Susan E. Birket, et al.. (2020). Novel Therapy of Bicarbonate, Glutathione, and Ascorbic Acid Improves Cystic Fibrosis Mucus Transport. American Journal of Respiratory Cell and Molecular Biology. 63(3). 362–373. 13 indexed citations
14.
Leung, Hui Min, Susan E. Birket, Timothy N. Ford, et al.. (2019). Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies. Science Translational Medicine. 11(504). 39 indexed citations
15.
Lin, Vivian, Niroop Kaza, Susan E. Birket, et al.. (2019). Excess mucus viscosity and airway dehydration impact COPD airway clearance. European Respiratory Journal. 55(1). 1900419–1900419. 52 indexed citations
16.
Keiser, Nicholas W., Susan E. Birket, Scott R. Tyler, et al.. (2014). Defective Innate Immunity and Hyperinflammation in Newborn Cystic Fibrosis Transmembrane Conductance Regulator–Knockout Ferret Lungs. American Journal of Respiratory Cell and Molecular Biology. 52(6). 683–694. 78 indexed citations
17.
Liu, Linbo, Suresh Shastry, Grace H. Houser, et al.. (2014). An Autoregulatory Mechanism Governing Mucociliary Transport Is Sensitive to Mucus Load. American Journal of Respiratory Cell and Molecular Biology. 51(4). 485–493. 60 indexed citations
18.
Birket, Susan E., Kengyeh K. Chu, Linbo Liu, et al.. (2014). A Functional Anatomic Defect of the Cystic Fibrosis Airway. American Journal of Respiratory and Critical Care Medicine. 190(4). 421–432. 115 indexed citations
19.
Cory, Theodore J., Susan E. Birket, Brian S. Murphy, et al.. (2013). Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis. Journal of Cystic Fibrosis. 13(2). 164–171. 29 indexed citations
20.
Cory, Theodore J., et al.. (2012). Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 68(4). 840–851. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Kühnel Breakdown of academic impact, for papers by Stefan Borgmann Breakdown of academic impact, for papers by Sang Rok Lee Breakdown of academic impact, for papers by Camille Ehré Breakdown of academic impact, for papers by Helen Williams Breakdown of academic impact, for papers by Andrew B. Tullo Breakdown of academic impact, for papers by Eileen Uribe‐Querol Breakdown of academic impact, for papers by Claudia Chalk Breakdown of academic impact, for papers by Mike Hasenberg Breakdown of academic impact, for papers by E Bastounis
Rankless by CCL
2026